Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in VYGR — Voyager Therapeutics, Inc.

CIK 1115418 BOSTON, MA
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$203,609
-$18,595 QoQ
Shares Held
58,174
+1.1% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 135 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. VYGR ranks #245 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in VYGR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $203,609 58,174
2026-03-31 $222,204 57,566
2025-12-31 $231,559 58,921
2025-09-30 $326,857 69,991
2025-06-30 $212,372 68,287
2025-03-31 $229,762 67,977
2024-12-31 $405,387 71,497
2024-09-30 $404,486 69,143
2024-06-30 $573,166 72,461
2024-03-31 $432,421 46,447
2023-12-31 $360,691 42,736
2023-09-30 $333,560 43,040
2023-06-30 $474,155 41,411
2021-03-31 $159,518 33,868
2020-12-31 $251,451 35,168
2020-09-30 $342,165 32,068
2020-06-30 $467,104 37,013
2020-03-31 $307,046 33,557